Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
- PMID: 23088346
- PMCID: PMC3494570
- DOI: 10.1186/1748-717X-7-176
Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma
Abstract
Background: To evaluate the impact of 18F-FDG PET/CT on target volume delineation in gynaecological cancer.
Methods: F-FDG PET/CT based RT treatment planning was performed in 10 patients with locally recurrent (n = 5) or post-surgical residual gynaecological cancer (n = 5). The gross tumor volume (GTV) was defined by 4 experienced radiation oncologists first using contrast enhanced CT (GTVCT) and secondly using the fused 18F-FDG PET/CT datasets (GTVPET/CT). In addition, the GTV was delineated using the signal-to-background (SBR) ratio-based adaptive thresholding technique (GTVSBR). Overlap analysis were conducted to assess geographic mismatches between the GTVs delineated using the different techniques. Inter- and intra-observer variability were also assessed.
Results: The mean GTVCT (43.65 cm3) was larger than the mean GTVPET/CT (33.06 cm3), p = 0.02. In 6 patients, GTVPET/CT added substantial tumor extension outside the GTVCT even though 90.4% of the GTVPET/CT was included in the GTVCT and 30.2% of the GTVCT was found outside the GTVPET/CT. The inter- and intra-observer variability was not significantly reduced with the inclusion of 18F-FDG PET imaging (p = 0.23 and p = 0.18, respectively). The GTVSBR was smaller than GTVCT p ≤ 0.005 and GTVPET/CT p ≤ 0.005.
Conclusions: The use of 18F-FDG PET/CT images for target volume delineation of recurrent or post-surgical residual gynaecological cancer alters the GTV in the majority of patients compared to standard CT-definition. The use of SBR-based auto-delineation showed significantly smaller GTVs. The use of PET/CT based target volume delineation may improve the accuracy of RT treatment planning in gynaecologic cancer.
Figures


References
-
- Kinkel K, Ariche M, Tardivon AA, Spatz A, Castaigne D, Lhomme C, Vanel D. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology. 1997;204:55–63. - PubMed
-
- Weber TM, Sostman HD, Spritzer CE, Ballard RL, Meyer GA, Clark-Pearson DL, Soper JT. Cervical carcinoma: determination of recurrent tumor extent versus radiation changes with MR imaging. Radiology. 1995;194:135–139. - PubMed
-
- Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK, Kang SB. The clinical impact of [(18)[F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings. Eur J Nucl Med Mol Imaging. 2008;35:1081–1088. doi: 10.1007/s00259-007-0687-8. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources